NCT04764292View on ClinicalTrials.gov

Screening Contrast-Enhanced Mammography as an Alternative to MRI

PHASE4CompletedINTERVENTIONAL
Enrollment

601

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions
Breast Cancer
Interventions
DEVICE

Contrast-enhanced mammography

supplemental breast cancer screening with contrast-enhanced mammography

DRUG

Iodinated Contrast Media (ICM)

supplemental breast cancer screening with contrast-enhanced mammography

Trial Locations (3)

15146

UPMC Magee Monroeville Breast Care Center, Pittsburgh

15213

Magee-Womens Hospital, Pittsburgh

16066

UPMC Magee at the Lemieux Sports Complex, Cranberry Township

All Listed Sponsors
collaborator

PA Breast Cancer Coalition

UNKNOWN

lead

Wendie Berg

OTHER

NCT04764292 - Screening Contrast-Enhanced Mammography as an Alternative to MRI | Biotech Hunter | Biotech Hunter